Kiryat Gat, Israel

Aharon Azaguri

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: B.g. Negev Technologies and Applications Ltd.. Active years: 2021.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aharon Azaguri: Innovator in Low Intensity Ultrasound Therapy

Introduction

Aharon Azaguri is a notable inventor based in Kiryat Gat, Israel. He has made significant contributions to the field of medical technology, particularly in the area of ultrasound therapy. His innovative approach focuses on treating diseases associated with hyperproliferating cells.

Latest Patents

Aharon Azaguri holds a patent for a method titled "Low intensity ultrasound therapy - Methods of treating a subject suffering from a disease or a disorder associated with hyperproliferating cells." This method involves non-invasively administering low-intensity ultrasound to selectively prevent the growth of hyperproliferating cells or eliminate them, while preserving the viability of normal cells. The ultrasound intensity is carefully calibrated to remain below the cavitational threshold for the selected frequency.

Career Highlights

Aharon Azaguri is associated with B.G. Negev Technologies and Applications Ltd., where he continues to develop and refine his innovative techniques. His work has the potential to revolutionize treatment options for various medical conditions.

Collaborations

Some of Aharon Azaguri's coworkers include Joseph Kost and Yana Yudilevich, who contribute to the collaborative efforts in advancing ultrasound therapy technologies.

Conclusion

Aharon Azaguri's work in low intensity ultrasound therapy exemplifies the intersection of innovation and medical science. His contributions are paving the way for new treatment methodologies that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…